Loading…

Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction

Left ventricular ejection fraction is a powerful independent predictor of survival in cardiac patients, especially those with coronary artery disease. Delayed-enhancement magnetic resonance imaging (DE-MRI) can accurately identify irreversible myocardial injury with high spatial and contrast resolut...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2009-11, Vol.120 (21), p.2069-2076
Main Authors: CHEONG, Benjamin Y. C, MUTHUPILLAI, Raja, WILSON, James M, SUNG, Angela, HUBER, Steffen, AMIN, Samir, ELAYDA, Macarthur A, LEE, Vei-Vei, FLAMM, Scott D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c333t-f0faa597dc7bda2d034f3a096111971117ab732fcfb4f96ab64b06d86917a62e3
container_end_page 2076
container_issue 21
container_start_page 2069
container_title Circulation (New York, N.Y.)
container_volume 120
creator CHEONG, Benjamin Y. C
MUTHUPILLAI, Raja
WILSON, James M
SUNG, Angela
HUBER, Steffen
AMIN, Samir
ELAYDA, Macarthur A
LEE, Vei-Vei
FLAMM, Scott D
description Left ventricular ejection fraction is a powerful independent predictor of survival in cardiac patients, especially those with coronary artery disease. Delayed-enhancement magnetic resonance imaging (DE-MRI) can accurately identify irreversible myocardial injury with high spatial and contrast resolution. To date, relatively limited data are available on the prognostic value of DE-MRI, so we sought to determine whether DE-MRI findings independently predict survival. The medical records of 857 consecutive patients who had complete cine and DE-MRI evaluation at a tertiary care center were reviewed regardless of whether the patients had coronary artery disease. The presence and extent of myocardial scar were evaluated qualitatively by a single experienced observer. The primary, composite end point was all-cause mortality or cardiac transplantation. Survival data were obtained from the Social Security Death Index. The median follow-up was 4.4 years; 252 patients (29%) reached one of the end points. Independent predictors of mortality or transplantation included congestive heart failure, ejection fraction, and age (P
doi_str_mv 10.1161/CIRCULATIONAHA.109.852517
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_734151257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>734151257</sourcerecordid><originalsourceid>FETCH-LOGICAL-c333t-f0faa597dc7bda2d034f3a096111971117ab732fcfb4f96ab64b06d86917a62e3</originalsourceid><addsrcrecordid>eNpVkdtu1DAQhq0K1G4Lr4DMBeIqiw9xvOZutW3pSguteoDLaOLYqVFiFzuptI_BG-PtrkDceOyZ7x9r5kfoPSVzSiv6abW-XT1slvfr62_Lq-WcEjVfCCaoPEIzKlhZlIKrV2hGCFGF5IydoNOUfuZnxaU4RidUKUKp4jP0-yaGzoc0Oo3vXOeddRq8NjhYfG562Jq2uPCPu9Rg_Ii_QufNDr41KfgXcj1A53z3Gd9N8dk9Q7_TLoTENzC6rEn4hxsfMfj25RKmEW-MHfH3XItOTz1EfL5NdvJ6dMG_Qa8t9Mm8PcQz9HB5cb-6KjbXX9ar5abQnPOxsMQCCCVbLZsWWEt4aTkQVdE8mMyHhCaPbrVtSqsqaKqyIVW7qFSuVMzwM_Rx3_cphl-TSWM9uKRN34M3YUq15CUVlAmZSbUndQwpRWPrp-gGiNuaknpnSP2_ITmt6r0hWfvu8MvUDKb9pzw4kIEPBwCSht7GvFOX_nKMUSkWTPA_E4CXjQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>734151257</pqid></control><display><type>article</type><title>Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction</title><source>Free E-Journal (出版社公開部分のみ)</source><creator>CHEONG, Benjamin Y. C ; MUTHUPILLAI, Raja ; WILSON, James M ; SUNG, Angela ; HUBER, Steffen ; AMIN, Samir ; ELAYDA, Macarthur A ; LEE, Vei-Vei ; FLAMM, Scott D</creator><creatorcontrib>CHEONG, Benjamin Y. C ; MUTHUPILLAI, Raja ; WILSON, James M ; SUNG, Angela ; HUBER, Steffen ; AMIN, Samir ; ELAYDA, Macarthur A ; LEE, Vei-Vei ; FLAMM, Scott D</creatorcontrib><description>Left ventricular ejection fraction is a powerful independent predictor of survival in cardiac patients, especially those with coronary artery disease. Delayed-enhancement magnetic resonance imaging (DE-MRI) can accurately identify irreversible myocardial injury with high spatial and contrast resolution. To date, relatively limited data are available on the prognostic value of DE-MRI, so we sought to determine whether DE-MRI findings independently predict survival. The medical records of 857 consecutive patients who had complete cine and DE-MRI evaluation at a tertiary care center were reviewed regardless of whether the patients had coronary artery disease. The presence and extent of myocardial scar were evaluated qualitatively by a single experienced observer. The primary, composite end point was all-cause mortality or cardiac transplantation. Survival data were obtained from the Social Security Death Index. The median follow-up was 4.4 years; 252 patients (29%) reached one of the end points. Independent predictors of mortality or transplantation included congestive heart failure, ejection fraction, and age (P&lt;0.0001 for each), as well as scar index (hazard ratio, 1.26; 95% confidence interval, 1.02 to 1.55; P=0.033). Similarly, in subsets of patients with or without coronary artery disease, scar index also independently predicted mortality or transplantation (hazard ratio, 1.33; 95% confidence interval, 1.05 to 1.68; P=0.018; and hazard ratio, 5.65; 95% confidence interval, 1.74 to 18.3; P=0.004, respectively). Cox regression analysis showed worse outcome in patients with any DE in addition to depressed left ventricular ejection fraction (&lt;50%). The degree of DE detected by DE-MRI appears to strongly predict all-cause mortality or cardiac transplantation after adjustment for traditional, well-known prognosticators.</description><identifier>ISSN: 0009-7322</identifier><identifier>EISSN: 1524-4539</identifier><identifier>DOI: 10.1161/CIRCULATIONAHA.109.852517</identifier><identifier>PMID: 19901193</identifier><identifier>CODEN: CIRCAZ</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adult ; Aged ; Biological and medical sciences ; Blood and lymphatic vessels ; Cardiology. Vascular system ; Cardiovascular system ; Coronary Artery Disease - mortality ; Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous ; Female ; Heart Transplantation ; Humans ; Image Enhancement ; Magnetic Resonance Imaging - methods ; Male ; Medical sciences ; Middle Aged ; Pharmacology. Drug treatments ; Prognosis ; Stroke Volume ; Vasodilator agents. Cerebral vasodilators ; Ventricular Dysfunction, Left - diagnosis ; Ventricular Dysfunction, Left - mortality</subject><ispartof>Circulation (New York, N.Y.), 2009-11, Vol.120 (21), p.2069-2076</ispartof><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c333t-f0faa597dc7bda2d034f3a096111971117ab732fcfb4f96ab64b06d86917a62e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22175825$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19901193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>CHEONG, Benjamin Y. C</creatorcontrib><creatorcontrib>MUTHUPILLAI, Raja</creatorcontrib><creatorcontrib>WILSON, James M</creatorcontrib><creatorcontrib>SUNG, Angela</creatorcontrib><creatorcontrib>HUBER, Steffen</creatorcontrib><creatorcontrib>AMIN, Samir</creatorcontrib><creatorcontrib>ELAYDA, Macarthur A</creatorcontrib><creatorcontrib>LEE, Vei-Vei</creatorcontrib><creatorcontrib>FLAMM, Scott D</creatorcontrib><title>Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction</title><title>Circulation (New York, N.Y.)</title><addtitle>Circulation</addtitle><description>Left ventricular ejection fraction is a powerful independent predictor of survival in cardiac patients, especially those with coronary artery disease. Delayed-enhancement magnetic resonance imaging (DE-MRI) can accurately identify irreversible myocardial injury with high spatial and contrast resolution. To date, relatively limited data are available on the prognostic value of DE-MRI, so we sought to determine whether DE-MRI findings independently predict survival. The medical records of 857 consecutive patients who had complete cine and DE-MRI evaluation at a tertiary care center were reviewed regardless of whether the patients had coronary artery disease. The presence and extent of myocardial scar were evaluated qualitatively by a single experienced observer. The primary, composite end point was all-cause mortality or cardiac transplantation. Survival data were obtained from the Social Security Death Index. The median follow-up was 4.4 years; 252 patients (29%) reached one of the end points. Independent predictors of mortality or transplantation included congestive heart failure, ejection fraction, and age (P&lt;0.0001 for each), as well as scar index (hazard ratio, 1.26; 95% confidence interval, 1.02 to 1.55; P=0.033). Similarly, in subsets of patients with or without coronary artery disease, scar index also independently predicted mortality or transplantation (hazard ratio, 1.33; 95% confidence interval, 1.05 to 1.68; P=0.018; and hazard ratio, 5.65; 95% confidence interval, 1.74 to 18.3; P=0.004, respectively). Cox regression analysis showed worse outcome in patients with any DE in addition to depressed left ventricular ejection fraction (&lt;50%). The degree of DE detected by DE-MRI appears to strongly predict all-cause mortality or cardiac transplantation after adjustment for traditional, well-known prognosticators.</description><subject>Adult</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Blood and lymphatic vessels</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular system</subject><subject>Coronary Artery Disease - mortality</subject><subject>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</subject><subject>Female</subject><subject>Heart Transplantation</subject><subject>Humans</subject><subject>Image Enhancement</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Stroke Volume</subject><subject>Vasodilator agents. Cerebral vasodilators</subject><subject>Ventricular Dysfunction, Left - diagnosis</subject><subject>Ventricular Dysfunction, Left - mortality</subject><issn>0009-7322</issn><issn>1524-4539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNpVkdtu1DAQhq0K1G4Lr4DMBeIqiw9xvOZutW3pSguteoDLaOLYqVFiFzuptI_BG-PtrkDceOyZ7x9r5kfoPSVzSiv6abW-XT1slvfr62_Lq-WcEjVfCCaoPEIzKlhZlIKrV2hGCFGF5IydoNOUfuZnxaU4RidUKUKp4jP0-yaGzoc0Oo3vXOeddRq8NjhYfG562Jq2uPCPu9Rg_Ii_QufNDr41KfgXcj1A53z3Gd9N8dk9Q7_TLoTENzC6rEn4hxsfMfj25RKmEW-MHfH3XItOTz1EfL5NdvJ6dMG_Qa8t9Mm8PcQz9HB5cb-6KjbXX9ar5abQnPOxsMQCCCVbLZsWWEt4aTkQVdE8mMyHhCaPbrVtSqsqaKqyIVW7qFSuVMzwM_Rx3_cphl-TSWM9uKRN34M3YUq15CUVlAmZSbUndQwpRWPrp-gGiNuaknpnSP2_ITmt6r0hWfvu8MvUDKb9pzw4kIEPBwCSht7GvFOX_nKMUSkWTPA_E4CXjQ</recordid><startdate>20091124</startdate><enddate>20091124</enddate><creator>CHEONG, Benjamin Y. C</creator><creator>MUTHUPILLAI, Raja</creator><creator>WILSON, James M</creator><creator>SUNG, Angela</creator><creator>HUBER, Steffen</creator><creator>AMIN, Samir</creator><creator>ELAYDA, Macarthur A</creator><creator>LEE, Vei-Vei</creator><creator>FLAMM, Scott D</creator><general>Lippincott Williams &amp; Wilkins</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20091124</creationdate><title>Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction</title><author>CHEONG, Benjamin Y. C ; MUTHUPILLAI, Raja ; WILSON, James M ; SUNG, Angela ; HUBER, Steffen ; AMIN, Samir ; ELAYDA, Macarthur A ; LEE, Vei-Vei ; FLAMM, Scott D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c333t-f0faa597dc7bda2d034f3a096111971117ab732fcfb4f96ab64b06d86917a62e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Blood and lymphatic vessels</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular system</topic><topic>Coronary Artery Disease - mortality</topic><topic>Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous</topic><topic>Female</topic><topic>Heart Transplantation</topic><topic>Humans</topic><topic>Image Enhancement</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Stroke Volume</topic><topic>Vasodilator agents. Cerebral vasodilators</topic><topic>Ventricular Dysfunction, Left - diagnosis</topic><topic>Ventricular Dysfunction, Left - mortality</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>CHEONG, Benjamin Y. C</creatorcontrib><creatorcontrib>MUTHUPILLAI, Raja</creatorcontrib><creatorcontrib>WILSON, James M</creatorcontrib><creatorcontrib>SUNG, Angela</creatorcontrib><creatorcontrib>HUBER, Steffen</creatorcontrib><creatorcontrib>AMIN, Samir</creatorcontrib><creatorcontrib>ELAYDA, Macarthur A</creatorcontrib><creatorcontrib>LEE, Vei-Vei</creatorcontrib><creatorcontrib>FLAMM, Scott D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>CHEONG, Benjamin Y. C</au><au>MUTHUPILLAI, Raja</au><au>WILSON, James M</au><au>SUNG, Angela</au><au>HUBER, Steffen</au><au>AMIN, Samir</au><au>ELAYDA, Macarthur A</au><au>LEE, Vei-Vei</au><au>FLAMM, Scott D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction</atitle><jtitle>Circulation (New York, N.Y.)</jtitle><addtitle>Circulation</addtitle><date>2009-11-24</date><risdate>2009</risdate><volume>120</volume><issue>21</issue><spage>2069</spage><epage>2076</epage><pages>2069-2076</pages><issn>0009-7322</issn><eissn>1524-4539</eissn><coden>CIRCAZ</coden><abstract>Left ventricular ejection fraction is a powerful independent predictor of survival in cardiac patients, especially those with coronary artery disease. Delayed-enhancement magnetic resonance imaging (DE-MRI) can accurately identify irreversible myocardial injury with high spatial and contrast resolution. To date, relatively limited data are available on the prognostic value of DE-MRI, so we sought to determine whether DE-MRI findings independently predict survival. The medical records of 857 consecutive patients who had complete cine and DE-MRI evaluation at a tertiary care center were reviewed regardless of whether the patients had coronary artery disease. The presence and extent of myocardial scar were evaluated qualitatively by a single experienced observer. The primary, composite end point was all-cause mortality or cardiac transplantation. Survival data were obtained from the Social Security Death Index. The median follow-up was 4.4 years; 252 patients (29%) reached one of the end points. Independent predictors of mortality or transplantation included congestive heart failure, ejection fraction, and age (P&lt;0.0001 for each), as well as scar index (hazard ratio, 1.26; 95% confidence interval, 1.02 to 1.55; P=0.033). Similarly, in subsets of patients with or without coronary artery disease, scar index also independently predicted mortality or transplantation (hazard ratio, 1.33; 95% confidence interval, 1.05 to 1.68; P=0.018; and hazard ratio, 5.65; 95% confidence interval, 1.74 to 18.3; P=0.004, respectively). Cox regression analysis showed worse outcome in patients with any DE in addition to depressed left ventricular ejection fraction (&lt;50%). The degree of DE detected by DE-MRI appears to strongly predict all-cause mortality or cardiac transplantation after adjustment for traditional, well-known prognosticators.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>19901193</pmid><doi>10.1161/CIRCULATIONAHA.109.852517</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0009-7322
ispartof Circulation (New York, N.Y.), 2009-11, Vol.120 (21), p.2069-2076
issn 0009-7322
1524-4539
language eng
recordid cdi_proquest_miscellaneous_734151257
source Free E-Journal (出版社公開部分のみ)
subjects Adult
Aged
Biological and medical sciences
Blood and lymphatic vessels
Cardiology. Vascular system
Cardiovascular system
Coronary Artery Disease - mortality
Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
Female
Heart Transplantation
Humans
Image Enhancement
Magnetic Resonance Imaging - methods
Male
Medical sciences
Middle Aged
Pharmacology. Drug treatments
Prognosis
Stroke Volume
Vasodilator agents. Cerebral vasodilators
Ventricular Dysfunction, Left - diagnosis
Ventricular Dysfunction, Left - mortality
title Prognostic Significance of Delayed-Enhancement Magnetic Resonance Imaging: Survival of 857 Patients With and Without Left Ventricular Dysfunction
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T06%3A04%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prognostic%20Significance%20of%20Delayed-Enhancement%20Magnetic%20Resonance%20Imaging:%20Survival%20of%20857%20Patients%20With%20and%20Without%20Left%20Ventricular%20Dysfunction&rft.jtitle=Circulation%20(New%20York,%20N.Y.)&rft.au=CHEONG,%20Benjamin%20Y.%20C&rft.date=2009-11-24&rft.volume=120&rft.issue=21&rft.spage=2069&rft.epage=2076&rft.pages=2069-2076&rft.issn=0009-7322&rft.eissn=1524-4539&rft.coden=CIRCAZ&rft_id=info:doi/10.1161/CIRCULATIONAHA.109.852517&rft_dat=%3Cproquest_cross%3E734151257%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c333t-f0faa597dc7bda2d034f3a096111971117ab732fcfb4f96ab64b06d86917a62e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=734151257&rft_id=info:pmid/19901193&rfr_iscdi=true